In this study, we found that the severe OHSS rate in the follicular phase GnRH agonist group was significantly higher than that of the fixed GnRH antagonist group, but no statistical differences were observed in the biochemical pregnancy rates and the clinical pregnancy rates of the two groups. This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.